| 1. |
YOKOYAMA T, MIYAUCHI K, KURATA T. Effect of probucol on neointimal thickening in a stent porcine restenosis model[J]. Jpn Heart J, 2004, 45(2):305-13.
|
| 2. |
賈偉華,周立春,田桂林. 普羅布考對頸動脈粥樣硬化斑塊穩定性影響的臨床研究[J].中國新藥雜志, 2007,16:237-239.
|
| 3. |
FORTI N, RAMIRES JA. Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study[J]. Arq Bras Cardiol, 1991, 57(3):25361.
|
| 4. |
JEON SM, PARK YB, KWON OS, et al. Vitamin E supplementation alters HDLcholesterol concentration and paraoxonase activity in rabbits fed highcholesterol diet: comparison with probucol[J]. J Biochem Mol Toxicol, 2005, 19(5):336-46.
|
| 5. |
HONG SC, ZHAO SP, WU ZH. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SRBI) expression in the liver of hypercholesterolemic rabbits[J]. Int J Cardiol, 2007, 115(1):29-35.
|
| 6. |
傅 琛,夏強,曹春梅,等.活性氧,NO和線粒體ATP敏感鉀通道在TNF2A預處理對缺血/再灌注心肌保護中的作用[J].中國應用生理學雜志,2005,21(1):20-24.
|
| 7. |
HONG SC, ZHAO SP, WU ZH.Probucol upregulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits[J]. J Cardiovasc Pharmacol, 2006, 47(1):77-81.
|
| 8. |
顧江濤,屈文昌,張安,丙丁酚對冠心病及其高位人群血管內皮功能失調的作用[J].臨床心血管病雜志, 2006,22(2):117-118.
|
| 9. |
FRUEBIS J, SILVESTRE M, SHELTON D, et al. Inhibition of VCAM1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits[J]. J Lipid Res, 1999, 40(11):1958-66.
|
| 10. |
ADLOUNI A, EL MESSAL M, SA?LE R. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AIcontaining lipoprotein particles[J]. Atherosclerosis, 2000,152(2):433-40.
|
| 11. |
SUKHOVA GK, SCH?NBECK U, RABKIN E. Evidence for increased collagenolysis by interstitial collagenases1 and 3 in vulnerable human atheromatous plaques[J]. Circulation, 1999,18; 99(19):2503-9.
|